ID   FCN3_HUMAN              Reviewed;         299 AA.
AC   O75636; Q6IBJ5; Q8WW86;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   07-MAR-2006, sequence version 2.
DT   03-AUG-2022, entry version 208.
DE   RecName: Full=Ficolin-3;
DE   AltName: Full=Collagen/fibrinogen domain-containing lectin 3 p35;
DE   AltName: Full=Collagen/fibrinogen domain-containing protein 3;
DE   AltName: Full=Hakata antigen;
DE   Flags: Precursor;
GN   Name=FCN3; Synonyms=FCNH, HAKA1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PARTIAL PROTEIN SEQUENCE, AND
RP   HYDROXYLATION AT PRO-50; PRO-53; PRO-59; PRO-65; PRO-68 AND PRO-77.
RC   TISSUE=Lung;
RX   PubMed=9694814; DOI=10.1074/jbc.273.33.20721;
RA   Sugimoto R., Yae Y., Akaiwa M., Kitajima S., Shibata Y., Sato H.,
RA   Hirata J., Okochi K., Izuhara K., Hamasaki N.;
RT   "Cloning and characterization of the Hakata antigen, a member of the
RT   ficolin/opsonin p35 lectin family.";
RL   J. Biol. Chem. 273:20721-20727(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   SeattleSNPs variation discovery resource;
RL   Submitted (SEP-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 24-38.
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally verified
RT   cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
RN   [8]
RP   TISSUE SPECIFICITY.
RX   PubMed=10330454; DOI=10.1177/002215549904700607;
RA   Akaiwa M., Yae Y., Sugimoto R., Suzuki S.O., Iwaki T., Izuhara K.,
RA   Hamasaki N.;
RT   "Hakata antigen, a new member of the ficolin/opsonin p35 family, is a novel
RT   human lectin secreted into bronchus/alveolus and bile.";
RL   J. Histochem. Cytochem. 47:777-786(1999).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH MASP1 AND MASP2.
RX   PubMed=11907111; DOI=10.4049/jimmunol.168.7.3502;
RA   Matsushita M., Kuraya M., Hamasaki N., Tsujimura M., Shiraki H., Fujita T.;
RT   "Activation of the lectin complement pathway by H-ficolin (Hakata
RT   antigen).";
RL   J. Immunol. 168:3502-3506(2002).
RN   [10]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-189.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J.,
RA   Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [11]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-189.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of multiple
RT   enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [12]
RP   GLYCOSYLATION AT ASN-189.
RX   PubMed=19139490; DOI=10.1074/mcp.m800504-mcp200;
RA   Jia W., Lu Z., Fu Y., Wang H.P., Wang L.H., Chi H., Yuan Z.F., Zheng Z.B.,
RA   Song L.N., Han H.H., Liang Y.M., Wang J.L., Cai Y., Zhang Y.K., Deng Y.L.,
RA   Ying W.T., He S.M., Qian X.H.;
RT   "A strategy for precise and large scale identification of core fucosylated
RT   glycoproteins.";
RL   Mol. Cell. Proteomics 8:913-923(2009).
RN   [13]
RP   INVOLVEMENT IN FCN3D.
RX   PubMed=19535802; DOI=10.1056/nejmoa0900381;
RA   Munthe-Fog L., Hummelshoj T., Honore C., Madsen H.O., Permin H., Garred P.;
RT   "Immunodeficiency associated with FCN3 mutation and ficolin-3 deficiency.";
RL   N. Engl. J. Med. 360:2637-2644(2009).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.73 ANGSTROMS) OF 79-299 IN COMPLEX WITH CALCIUM
RP   AND GALACTOSE, DISULFIDE BONDS, SUBUNIT, AND FUNCTION.
RX   PubMed=17215869; DOI=10.1038/sj.emboj.7601500;
RA   Garlatti V., Belloy N., Martin L., Lacroix M., Matsushita M., Endo Y.,
RA   Fujita T., Fontecilla-Camps J.C., Arlaud G.J., Thielens N.M., Gaboriaud C.;
RT   "Structural insights into the innate immune recognition specificities of
RT   L- and H-ficolins.";
RL   EMBO J. 26:623-633(2007).
CC   -!- FUNCTION: May function in innate immunity through activation of the
CC       lectin complement pathway. Calcium-dependent and GlcNAc-binding lectin.
CC       Has affinity with GalNAc, GlcNAc, D-fucose, as mono/oligosaccharide and
CC       lipopolysaccharides from S.typhimurium and S.minnesota.
CC       {ECO:0000269|PubMed:11907111, ECO:0000269|PubMed:17215869}.
CC   -!- SUBUNIT: Homotrimer (PubMed:17215869). May form an octadecamer
CC       consisting of an elementary trimer unit. Does not interact with
CC       fibronectin, elastin or zymosan. Interacts with MASP1 and MASP2.
CC       {ECO:0000269|PubMed:11907111, ECO:0000269|PubMed:17215869}.
CC   -!- INTERACTION:
CC       O75636; P17927: CR1; NbExp=2; IntAct=EBI-11786958, EBI-2807625;
CC       O75636; Q15485: FCN2; NbExp=12; IntAct=EBI-11786958, EBI-7468784;
CC       O75636; P02751: FN1; NbExp=3; IntAct=EBI-11786958, EBI-1220319;
CC       O75636; P48740-2: MASP1; NbExp=5; IntAct=EBI-11786958, EBI-26435098;
CC       O75636; P48740-3: MASP1; NbExp=3; IntAct=EBI-11786958, EBI-26435118;
CC       O75636; PRO_0000000214 [P9WQP3]: fbpA; Xeno; NbExp=2; IntAct=EBI-11786958, EBI-26878164;
CC       O75636; P9WQP1: fbpB; Xeno; NbExp=4; IntAct=EBI-11786958, EBI-26878221;
CC       PRO_0000009142; PRO_0000009142 [O75636]: FCN3; NbExp=2; IntAct=EBI-27105453, EBI-27105453;
CC   -!- SUBCELLULAR LOCATION: Secreted. Note=Found in blood plasma, bronchus,
CC       alveolus and bile duct.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O75636-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O75636-2; Sequence=VSP_001541;
CC   -!- TISSUE SPECIFICITY: Liver and lung. In liver it is produced by bile
CC       duct epithelial cells and hepatocytes. In lung it is produced by both
CC       ciliated bronchial epithelial cells and type II alveolar epithelial
CC       cells. {ECO:0000269|PubMed:10330454}.
CC   -!- PTM: The N-terminus is blocked.
CC   -!- DISEASE: Ficolin 3 deficiency (FCN3D) [MIM:613860]: A disorder
CC       characterized by immunodeficiency, recurrent infections, brain
CC       abscesses and recurrent warts on the fingers. Affected individuals have
CC       normal levels of lymphocytes, normal T-cell responses, and normal
CC       antibodies, but a selective deficient antibody response to pneumococcal
CC       polysaccharide vaccine. {ECO:0000269|PubMed:19535802}. Note=The disease
CC       is caused by variants affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the ficolin lectin family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/fcn3/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D88587; BAA32277.1; -; mRNA.
DR   EMBL; AK075140; BAC11429.1; -; mRNA.
DR   EMBL; CR456808; CAG33089.1; -; mRNA.
DR   EMBL; AY756173; AAU85296.1; -; Genomic_DNA.
DR   EMBL; FO393419; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC020731; AAH20731.1; -; mRNA.
DR   CCDS; CCDS300.1; -. [O75636-1]
DR   CCDS; CCDS301.1; -. [O75636-2]
DR   RefSeq; NP_003656.2; NM_003665.3. [O75636-1]
DR   RefSeq; NP_775628.1; NM_173452.2. [O75636-2]
DR   PDB; 2J5Z; X-ray; 1.73 A; A/B/C=79-299.
DR   PDB; 2J60; X-ray; 1.80 A; A/B/C=79-299.
DR   PDB; 2J64; X-ray; 2.20 A; A/B/C=79-299.
DR   PDBsum; 2J5Z; -.
DR   PDBsum; 2J60; -.
DR   PDBsum; 2J64; -.
DR   AlphaFoldDB; O75636; -.
DR   SMR; O75636; -.
DR   BioGRID; 114117; 56.
DR   ComplexPortal; CPX-6179; FCN3-MASP1 lectin-protease complex.
DR   ComplexPortal; CPX-6239; FCN3-MASP2 lectin-protease complex.
DR   IntAct; O75636; 13.
DR   STRING; 9606.ENSP00000270879; -.
DR   DrugBank; DB01593; Zinc.
DR   DrugBank; DB14487; Zinc acetate.
DR   UniLectin; O75636; -.
DR   GlyConnect; 1247; 2 N-Linked glycans (1 site).
DR   GlyGen; O75636; 1 site, 4 N-linked glycans (1 site).
DR   iPTMnet; O75636; -.
DR   PhosphoSitePlus; O75636; -.
DR   BioMuta; FCN3; -.
DR   CPTAC; non-CPTAC-1124; -.
DR   jPOST; O75636; -.
DR   MassIVE; O75636; -.
DR   PaxDb; O75636; -.
DR   PeptideAtlas; O75636; -.
DR   PRIDE; O75636; -.
DR   ProteomicsDB; 50132; -. [O75636-1]
DR   ProteomicsDB; 50133; -. [O75636-2]
DR   Antibodypedia; 30776; 255 antibodies from 27 providers.
DR   DNASU; 8547; -.
DR   Ensembl; ENST00000270879.9; ENSP00000270879.4; ENSG00000142748.13. [O75636-1]
DR   Ensembl; ENST00000354982.2; ENSP00000347077.2; ENSG00000142748.13. [O75636-2]
DR   GeneID; 8547; -.
DR   KEGG; hsa:8547; -.
DR   MANE-Select; ENST00000270879.9; ENSP00000270879.4; NM_003665.4; NP_003656.2.
DR   UCSC; uc001boa.4; human. [O75636-1]
DR   CTD; 8547; -.
DR   DisGeNET; 8547; -.
DR   GeneCards; FCN3; -.
DR   HGNC; HGNC:3625; FCN3.
DR   HPA; ENSG00000142748; Group enriched (liver, lung).
DR   MalaCards; FCN3; -.
DR   MIM; 604973; gene.
DR   MIM; 613860; phenotype.
DR   neXtProt; NX_O75636; -.
DR   OpenTargets; ENSG00000142748; -.
DR   Orphanet; 331190; Immunodeficiency due to ficolin3 deficiency.
DR   PharmGKB; PA28071; -.
DR   VEuPathDB; HostDB:ENSG00000142748; -.
DR   eggNOG; KOG2579; Eukaryota.
DR   GeneTree; ENSGT00940000163188; -.
DR   HOGENOM; CLU_038628_6_0_1; -.
DR   InParanoid; O75636; -.
DR   OMA; GNCAVIV; -.
DR   PhylomeDB; O75636; -.
DR   TreeFam; TF351983; -.
DR   PathwayCommons; O75636; -.
DR   Reactome; R-HSA-166662; Lectin pathway of complement activation.
DR   Reactome; R-HSA-166663; Initial triggering of complement.
DR   Reactome; R-HSA-2855086; Ficolins bind to repetitive carbohydrate structures on the target cell surface.
DR   SignaLink; O75636; -.
DR   SIGNOR; O75636; -.
DR   BioGRID-ORCS; 8547; 6 hits in 1060 CRISPR screens.
DR   ChiTaRS; FCN3; human.
DR   EvolutionaryTrace; O75636; -.
DR   GeneWiki; FCN3; -.
DR   GenomeRNAi; 8547; -.
DR   Pharos; O75636; Tbio.
DR   PRO; PR:O75636; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; O75636; protein.
DR   Bgee; ENSG00000142748; Expressed in right lung and 103 other tissues.
DR   ExpressionAtlas; O75636; baseline and differential.
DR   Genevisible; O75636; HS.
DR   GO; GO:0072562; C:blood microparticle; HDA:UniProtKB.
DR   GO; GO:0005581; C:collagen trimer; IEA:UniProtKB-KW.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IBA:GO_Central.
DR   GO; GO:0009897; C:external side of plasma membrane; IC:ComplexPortal.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:1905370; C:serine-type endopeptidase complex; IDA:ComplexPortal.
DR   GO; GO:0003823; F:antigen binding; IDA:UniProtKB.
DR   GO; GO:0030246; F:carbohydrate binding; TAS:ProtInc.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0002752; P:cell surface pattern recognition receptor signaling pathway; IC:ComplexPortal.
DR   GO; GO:0006956; P:complement activation; IDA:UniProtKB.
DR   GO; GO:0001867; P:complement activation, lectin pathway; IDA:UniProtKB.
DR   GO; GO:0051607; P:defense response to virus; IDA:UniProtKB.
DR   GO; GO:1902679; P:negative regulation of RNA biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0046597; P:negative regulation of viral entry into host cell; IMP:UniProtKB.
DR   GO; GO:1903028; P:positive regulation of opsonization; IDA:ComplexPortal.
DR   GO; GO:0006508; P:proteolysis; IDA:ComplexPortal.
DR   GO; GO:0043654; P:recognition of apoptotic cell; IDA:UniProtKB.
DR   CDD; cd00087; FReD; 1.
DR   Gene3D; 3.90.215.10; -; 1.
DR   InterPro; IPR036056; Fibrinogen-like_C.
DR   InterPro; IPR014716; Fibrinogen_a/b/g_C_1.
DR   InterPro; IPR002181; Fibrinogen_a/b/g_C_dom.
DR   InterPro; IPR020837; Fibrinogen_CS.
DR   Pfam; PF00147; Fibrinogen_C; 1.
DR   SMART; SM00186; FBG; 1.
DR   SUPFAM; SSF56496; SSF56496; 1.
DR   PROSITE; PS00514; FIBRINOGEN_C_1; 1.
DR   PROSITE; PS51406; FIBRINOGEN_C_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Collagen;
KW   Complement activation lectin pathway; Direct protein sequencing;
KW   Disulfide bond; Glycoprotein; Hydroxylation; Immunity; Innate immunity;
KW   Lectin; Metal-binding; Reference proteome; Repeat; Secreted; Signal.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000269|PubMed:15340161"
FT   CHAIN           24..299
FT                   /note="Ficolin-3"
FT                   /id="PRO_0000009142"
FT   DOMAIN          48..80
FT                   /note="Collagen-like"
FT   DOMAIN          84..299
FT                   /note="Fibrinogen C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00739"
FT   REGION          44..81
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        57..74
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         237
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:17215869,
FT                   ECO:0007744|PDB:2J5Z, ECO:0007744|PDB:2J60"
FT   BINDING         239
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:17215869,
FT                   ECO:0007744|PDB:2J5Z, ECO:0007744|PDB:2J60"
FT   BINDING         241
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:17215869,
FT                   ECO:0007744|PDB:2J5Z, ECO:0007744|PDB:2J60"
FT   BINDING         243
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:17215869,
FT                   ECO:0007744|PDB:2J5Z, ECO:0007744|PDB:2J60"
FT   BINDING         258..259
FT                   /ligand="a carbohydrate"
FT                   /ligand_id="ChEBI:CHEBI:16646"
FT                   /evidence="ECO:0000305|PubMed:17215869"
FT   MOD_RES         50
FT                   /note="Hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:9694814"
FT   MOD_RES         53
FT                   /note="Hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:9694814"
FT   MOD_RES         59
FT                   /note="Hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:9694814"
FT   MOD_RES         65
FT                   /note="Hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:9694814"
FT   MOD_RES         68
FT                   /note="Hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:9694814"
FT   MOD_RES         77
FT                   /note="Hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:9694814"
FT   CARBOHYD        189
FT                   /note="N-linked (GlcNAc...) (complex) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16335952,
FT                   ECO:0000269|PubMed:19139490, ECO:0000269|PubMed:19159218"
FT   DISULFID        86..110
FT                   /evidence="ECO:0000269|PubMed:17215869,
FT                   ECO:0007744|PDB:2J5Z, ECO:0007744|PDB:2J60"
FT   DISULFID        93..121
FT                   /evidence="ECO:0000269|PubMed:17215869,
FT                   ECO:0007744|PDB:2J5Z, ECO:0007744|PDB:2J60"
FT   DISULFID        245..258
FT                   /evidence="ECO:0000269|PubMed:17215869,
FT                   ECO:0007744|PDB:2J5Z, ECO:0007744|PDB:2J60"
FT   VAR_SEQ         79..89
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_001541"
FT   CONFLICT        271
FT                   /note="E -> D (in Ref. 1; BAA32277 and 6; AAH20731)"
FT                   /evidence="ECO:0000305"
FT   HELIX           93..98
FT                   /evidence="ECO:0007829|PDB:2J5Z"
FT   STRAND          103..110
FT                   /evidence="ECO:0007829|PDB:2J5Z"
FT   STRAND          116..122
FT                   /evidence="ECO:0007829|PDB:2J5Z"
FT   HELIX           125..127
FT                   /evidence="ECO:0007829|PDB:2J5Z"
FT   STRAND          130..139
FT                   /evidence="ECO:0007829|PDB:2J5Z"
FT   HELIX           147..152
FT                   /evidence="ECO:0007829|PDB:2J5Z"
FT   STRAND          154..156
FT                   /evidence="ECO:0007829|PDB:2J5Z"
FT   HELIX           165..172
FT                   /evidence="ECO:0007829|PDB:2J5Z"
FT   STRAND          173..175
FT                   /evidence="ECO:0007829|PDB:2J5Z"
FT   STRAND          178..184
FT                   /evidence="ECO:0007829|PDB:2J5Z"
FT   STRAND          190..196
FT                   /evidence="ECO:0007829|PDB:2J5Z"
FT   STRAND          198..200
FT                   /evidence="ECO:0007829|PDB:2J5Z"
FT   HELIX           203..205
FT                   /evidence="ECO:0007829|PDB:2J5Z"
FT   STRAND          209..211
FT                   /evidence="ECO:0007829|PDB:2J5Z"
FT   STRAND          214..216
FT                   /evidence="ECO:0007829|PDB:2J60"
FT   HELIX           224..226
FT                   /evidence="ECO:0007829|PDB:2J5Z"
FT   STRAND          239..243
FT                   /evidence="ECO:0007829|PDB:2J5Z"
FT   HELIX           245..249
FT                   /evidence="ECO:0007829|PDB:2J5Z"
FT   STRAND          256..258
FT                   /evidence="ECO:0007829|PDB:2J5Z"
FT   STRAND          269..271
FT                   /evidence="ECO:0007829|PDB:2J5Z"
FT   TURN            282..285
FT                   /evidence="ECO:0007829|PDB:2J5Z"
FT   STRAND          292..299
FT                   /evidence="ECO:0007829|PDB:2J5Z"
SQ   SEQUENCE   299 AA;  32903 MW;  5CB8A7D3668FA364 CRC64;
     MDLLWILPSL WLLLLGGPAC LKTQEHPSCP GPRELEASKV VLLPSCPGAP GSPGEKGAPG
     PQGPPGPPGK MGPKGEPGDP VNLLRCQEGP RNCRELLSQG ATLSGWYHLC LPEGRALPVF
     CDMDTEGGGW LVFQRRQDGS VDFFRSWSSY RAGFGNQESE FWLGNENLHQ LTLQGNWELR
     VELEDFNGNR TFAHYATFRL LGEVDHYQLA LGKFSEGTAG DSLSLHSGRP FTTYDADHDS
     SNSNCAVIVH GAWWYASCYR SNLNGRYAVS EAAAHKYGID WASGRGVGHP YRRVRMMLR
//
